Pre-market Hot Trades in US Stocks

Onto Innovation is up 14.16% in pre-market trading. Based on recent key news:

1. On July 27, MarketBeat pointed out that although Onto Innovation received a buy rating from analysts, top analysts are more optimistic about five other stocks. This indicates that market confidence in Onto Innovation may not be as strong as in other stocks, even though its rating remains a buy.

2. On July 30, although Onto Innovation was not directly mentioned, the overall increased attention to tech stocks in the market may have indirectly driven up Onto Innovation's stock price. Increased attention to tech stocks has led to positive market sentiment.

STMicroelectronics is up 3.95% in pre-market trading. Based on recent key news:

1. On July 27, Berenberg raised the target price for STMicroelectronics from €53 to €68, with analyst Tammy Qiu maintaining a buy rating, boosting market confidence and driving the stock price up.

2. On July 28, Citigroup analyst Andrew Gardiner maintained a buy rating and set a target price of €62, further enhancing investor optimism for STMicroelectronics.

3. On July 30, STMicroelectronics reported strong revenue, profit, and earnings per share growth for the second quarter, with all business segments achieving organic growth and significantly improving cash flow. Despite challenges in the automotive market, the company maintains a positive outlook. The overall industry is performing well, supported by macroeconomic data.

Top Gainers in Pre-market US Stocks

Nuwellis is up 100.05% in pre-market trading. Based on recent key news:

1. On July 27, Nuwellis reported a preliminary revenue growth of 14% for the second quarter of 2026, significantly boosting the stock price. The company stated that this growth was primarily due to the commercial success of the Aquadex ultrafiltration platform.

2. On July 27, Nuwellis announced a 20% year-over-year revenue growth for the first half of 2026, further enhancing market confidence. The company plans to release its complete second-quarter financial report on August 13.

3. On July 27, Nuwellis's preliminary financial report showed an increased adoption rate of the Aquadex ultrafiltration platform, becoming the main driver of revenue growth. The medical device industry is experiencing strong growth, with high market attention.

T3 Defense is up 73.86% in pre-market trading. Based on recent key news:

1. On July 29, T3 Defense surged 81.56% during the trading session, currently reported at $23.785. This sharp increase is primarily driven by both technical and fundamental factors. The company's completed 1-for-125 reverse stock split has compressed the float to 1.12 million shares, triggering a technical short squeeze. Additionally, the company has made operational progress and achieved contract delivery in its Project 35 in the anti-drone technology field, with strategic investment news further boosting market confidence

2. On July 30, T3 Defense's stock price rose by 88%, currently reported at $45.12. The stock exhibits characteristics of "low float + high trading volume," leading to significant price fluctuations.

3. On July 28, T3 Defense's stock price increased by 130.76%, currently reported at $30.23. The company's subsidiary completed the delivery of an automated composite production line to a major Israeli manufacturer, further expanding its influence in the high-demand anti-drone technology sector. Defense investor X S.E. Security and Defense Ltd. acquired a 16.67% stake in the company in exchange for Project 35 equity, further boosting investor interest. The defense industry has recently performed strongly, with increased demand for anti-drone technology.

China Su Xuan Tang Pharmaceutical, pre-market up 61.71%, has no significant news recently. Trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation